HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

XYLOTOX 2 E80 overview
Local anaesthetic solution with vasoconstrictor for dental infiltration anaesthesia where a vasoconstrictor is indicated.
banner_pass = 1

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
XYLOTOX 2 E80
Drug Class Description :

Local anaesthetics.

Generic Name :

Lidocaine [lignocaine], adrenaline (epinephrine)

Drug description :

Solution for injection in cartridges for use in dental-type syringes.

Presentation :

Solution for injection, lidocaine hydrochloride monohydrate 24.65mg equivalent to lidocaine base 20mg and adrenaline hydrogen tartrate 25.0 micrograms corresponding to adrenaline 12.5 micrograms.

Indications :

Local anaesthetic solution with vasoconstrictor for dental infiltration anaesthesia where a vasoconstrictor is indicated.

Contra Indications :

Known hypersensitivity to anaesthetics of the amide type. Not for intravenous use. Contraindicated for anaesthesia of the fingers, toes, tip of nose and penis.

Special Precautions :

Epilepsy cardiac disease particularly with arrhythmia or hypertension, impaired respiratory function, thyrotoxicosis, hypovolaemia, acute porphyria and impaired hepatic function. Pregnancy and lactation. Avoid accidental intravascular injection.

Interactions :

Tricyclic antidepressants.

Adverse Reactions :

Reactions primarily of two types, typified by stimulation and depression of the cerebral cortex and medulla, respectively. Slow onset - stimulation leading to nervousness, dizziness, blurred vision, nausea, tremor, convulsions and respiratory arrest. Rapid onset - depression leading primarily to respiratory arrest, cardiovascular collapse and cardiac arrest.

Manufacturer :

AstraZeneca

Drug Availability :

(POM)

Drug Updated :

17 June 2009

Related Drugs - Muscle relaxants & premeds , Section 20A
Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. Niemann-Pick Type C Opioid and Pain Management - understanding, management, diagnosis and treatment information Ophthalmics - understanding, management, diagnosis and treatment information
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES